In this study, IGF‐1 treatment activated PI3K‐Akt‐mTOR signalling pathway, enlarged the resistance to radiotherapy, and elevated glucose uptake and the expression of HIF‐1α and Glut‐1 in laryngeal cancer cells. The gene discussed is IGF1; the disease is laryngeal carcinoma.